Pharmaceutical comprising ppar agonist

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/426 (2006.01) A61K 31/192 (2006.01) A61K 31/505 (2006.01) A61P 27/02 (2006.01)

Patent

CA 2630816

Disclosed is a proliferation-promoting agent for a meibomian gland epithelial cell or a corneal epithelial cell. Also disclosed is a therapeutic agent for an ophthalmic disease such as meibomian gland dysfunction and tear-evaporative dry eye. The proliferation promoting agent comprises a PPAR-.alpha. or - .gamma. agonist as an active ingredient. The therapeutic agent for an ophthalmic disease comprises a PPAR-.alpha. or -.gamma. agonist as an active ingredient.

L~invention concerne un agent favorisant la prolifération d~une cellule épithéliale d~une glande de Meibomius ou d~une cellule épithéliale cornéenne. Elle concerne également un agent thérapeutique pour traiter une maladie ophtalmique telle qu~un dysfonctionnement des glandes de Meibomius, et la sécheresse des yeux due à l~évaporation des larmes. L'agent favorisant la prolifération comprend un agoniste de PPAR-.alpha. ou -.gamma. comme principe actif. L'agent thérapeutique pour traiter une maladie ophtalmique comprend un agoniste de PPAR-.alpha. ou -.gamma. comme principe actif.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Pharmaceutical comprising ppar agonist does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical comprising ppar agonist, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical comprising ppar agonist will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1474989

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.